Quotient Clinical, an UK-based contract development organization, has expanded its clinical spray-drying capability through the acquisition of a Niro Mobile Minor Spray Dryer. Quotient has expertise in developing spray-dried dispersions to overcome drug compound solubility issues, and the addition of a larger-scale spray dryer will allow the production of a range of batch sizes, from milligrams up to two kilograms.

Sited at Quotient's new GMP facility at MediCity in Nottingham, UK, the facility is scheduled to open later in 2016. The company says that the expansion is in response to customer requests for ongoing product development support, including toxicology and later-stage clinical studies.

Source: Quotient Clinical